Definium Therapeutics, Inc. (DFTX) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Definium Therapeutics, Inc. (DFTX) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting $0.11 (capex $0.11 ) from operating cash flow of $24.19K. Explore Definium Therapeutics, Inc. cash conversion from operations to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.11
Capex + Investments
Operating Cash Flow
$24.19K
USD
Capital Expenditures
$0.11
USD
Annual Cash Flow Reinvestment Rate for Definium Therapeutics, Inc. (None–None)
Year-by-year capital reinvestment analysis for Definium Therapeutics, Inc.. For live market cap and broader valuation context, see DFTX stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow